Skip to main content

IQVIA Holdings Value Stock - Dividend - Research Selection

Iqvia s

ISIN: US46266C1053 , WKN: A2JSPM

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Is Wall Street Bullish or Bearish on IQVIA Holdings Stock?

2026-02-19
IQVIA Holdings has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day

2026-02-18
RESEARCH TRIANGLE PARK, N.C., February 18, 2026--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Ron Bruehlman, chief financial officer, and Mike Fedock, senior vice president, financial planning & analysis and incoming CFO, will speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026, at

Unlocking IQVIA (IQV) International Revenues: Trends, Surprises, and Prospects

2026-02-18
Explore IQVIA's (IQV) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

IXJ: Healthcare Sector Dashboard For February

2026-02-18

Waste Connections Stock Slides 7% Since Q4 Earnings Beat Estimates

2026-02-17
WCN shares fall 7% since fourth-quarter 2025 earnings topped estimates, as margin pressure, an operating loss and weaker recycling results weigh on sentiment.

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

2026-02-13
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Is the Options Market Predicting a Spike in IQVIA Stock?

2026-02-13
Investors need to pay close attention to IQVIA stock based on the movements in the options market lately.

Insperity Stock Price Decreases 18% After Reporting Loss in Q4

2026-02-12
NSP shares sink after the fourth-quarter 2025 loss, a revenue miss and a weak 2026 EPS outlook overshadow modest WSEE growth and a higher cash balance.

Thursday's session: gap up and gap down stock in the S&P500 index

2026-02-12
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

Get insights into the top movers in the S&P500 index of Thursday's pre-market session.

2026-02-12
Pre-market stock analysis of S&P500 stocks on 2026-02-12: top gainers and losers in today's session.